Cytostatic agents
    2.
    发明授权
    Cytostatic agents 失效
    细胞抑制剂

    公开(公告)号:US06462023B1

    公开(公告)日:2002-10-08

    申请号:US09100539

    申请日:1998-06-19

    IPC分类号: C07K506

    摘要: The present invention provide compounds exemplified by 2(R or S)-[2R-(S-Hydroxy-hydroxycarbamoyl-methyl)-4-methyl-pentanoylamine]-2-phenyl-ethanoic acid cyclopentyl ester; 2(R or S)-(3S-Hydroxycarbamoyl-2R-isobutyl-hex-5-enoylamino)-2-phenylethanoic acid isopropyl ester; 2(R or S)-[2R-(S-Hydroxycarbamoyi-methoxy-methyl)-4-methyl-pentanoylamino]-3-phenylethanoic acid cyclopentyl ester; 2(R or S)-(3S-Hydroxycarbamoyl-2R-isobutyl-hex-5-enoylamino)-2-(4-methoxyphenyl)ethanoic acid cyclopentyl ester; 2(R or S)-(3S-Hydroxycarbamoyl-2R-isobutyl-hex-5-enoylamino)-2-(thien-2-yl)ethanoic acid cyclopentyl ester; and 2(R or S)-(3S-Hydroxycarbamoyl-2R-isobutyl-hex-5-enoylamino)-2-(thien-3-yl)ethanoic acid cyclopentyl ester are cytostatic agents. Methods of treating proliferative cell growth disorders as well a methods of inhibiting hyper-proliferative cells are also disclosed.

    摘要翻译: 本发明提供了2(R或S) - [2R-(S-羟基 - 羟基氨基甲酰基 - 甲基)-4-甲基 - 戊酰胺] -2-苯基 - 乙酸环戊酯的实例化合物; 2(R或S) - (3S-羟基氨基甲酰基 - 2R-异丁基 - 己-5-烯酰基氨基)-2-苯基乙酸异丙酯; 2(R或S) - [2R-(S-羟基氨基甲酰基 - 甲氧基 - 甲基)-4-甲基 - 戊酰基氨基] -3-苯基乙酸环戊酯; 2(R或S) - (3S-羟基氨基甲酰基-2R-异丁基 - 己-5-烯酰基氨基)-2-(4-甲氧基苯基)乙酸环戊酯; 2(R或S) - (3S-羟基氨基甲酰基-R 2R-异丁基 - 己-5-烯酰基氨基)-2-(噻吩-2-基)乙酸环戊酯; 和2(R或S) - (3S-羟基氨基甲酰基-R 2R-异丁基 - 己-5-烯酰基氨基)-2-(噻吩-3-基)乙酸环戊酯是细胞抑制剂。 还公开了治疗增殖性细胞生长障碍的方法以及抑制高增殖细胞的方法。